JP2017160222A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017160222A5 JP2017160222A5 JP2017079525A JP2017079525A JP2017160222A5 JP 2017160222 A5 JP2017160222 A5 JP 2017160222A5 JP 2017079525 A JP2017079525 A JP 2017079525A JP 2017079525 A JP2017079525 A JP 2017079525A JP 2017160222 A5 JP2017160222 A5 JP 2017160222A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- integrin
- pharmaceutical composition
- binds
- native sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020001507 fusion proteins Proteins 0.000 claims 14
- 102000037865 fusion proteins Human genes 0.000 claims 14
- 102000006495 integrins Human genes 0.000 claims 14
- 108010044426 integrins Proteins 0.000 claims 14
- 238000000034 method Methods 0.000 claims 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 102000014736 Notch Human genes 0.000 claims 5
- 108010070047 Notch Receptors Proteins 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 210000002744 extracellular matrix Anatomy 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 238000007911 parenteral administration Methods 0.000 claims 2
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 claims 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 101710112927 Trypsin inhibitor 2 Proteins 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 238000010647 peptide synthesis reaction Methods 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41135010P | 2010-11-08 | 2010-11-08 | |
| US61/411,350 | 2010-11-08 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537908A Division JP6170435B2 (ja) | 2010-11-08 | 2011-11-07 | 改変ノッチンペプチドを含む融合タンパク質及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017160222A JP2017160222A (ja) | 2017-09-14 |
| JP2017160222A5 true JP2017160222A5 (OSRAM) | 2017-11-09 |
| JP6535361B2 JP6535361B2 (ja) | 2019-06-26 |
Family
ID=46051256
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537908A Active JP6170435B2 (ja) | 2010-11-08 | 2011-11-07 | 改変ノッチンペプチドを含む融合タンパク質及びその使用 |
| JP2017079525A Active JP6535361B2 (ja) | 2010-11-08 | 2017-04-13 | 改変ノッチンペプチドを含む融合タンパク質及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537908A Active JP6170435B2 (ja) | 2010-11-08 | 2011-11-07 | 改変ノッチンペプチドを含む融合タンパク質及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10844106B2 (OSRAM) |
| EP (2) | EP2638173B1 (OSRAM) |
| JP (2) | JP6170435B2 (OSRAM) |
| AU (3) | AU2011326164B2 (OSRAM) |
| CA (1) | CA2817197C (OSRAM) |
| DK (1) | DK2638173T3 (OSRAM) |
| WO (1) | WO2012064658A1 (OSRAM) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008045252A2 (en) * | 2006-10-04 | 2008-04-17 | The Board Of Trustees Of The Leland Stanford Junior University | Engineered integrin binding peptides |
| AU2011326164B2 (en) | 2010-11-08 | 2016-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| WO2013078250A2 (en) | 2011-11-22 | 2013-05-30 | The Board Of Trustees Of The Leland Stanford Junior University | Cystine knot peptides that bind alpha-v-beta-6 integrin |
| WO2013177187A2 (en) | 2012-05-22 | 2013-11-28 | Massachusetts Institute Of Technology | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents |
| WO2014063012A1 (en) | 2012-10-19 | 2014-04-24 | The Board Of Trustees Of The Leland Stanford Junior University | Conjugated knottin mini-proteins containing non-natural amino acids |
| RU2015126650A (ru) | 2012-12-10 | 2017-01-12 | Фред Хатчинсон Кэнсер Рисёрч Сентер | Партнеры липокалина по слиянию |
| ES2665323T7 (es) | 2012-12-14 | 2023-06-15 | Univ Leland Stanford Junior | Péptidos de AXL modificados y su uso en la inhibición de la señalización de AXL en terapia anti-metastásica |
| US11559580B1 (en) | 2013-09-17 | 2023-01-24 | Blaze Bioscience, Inc. | Tissue-homing peptide conjugates and methods of use thereof |
| EP3180018B1 (en) * | 2014-08-12 | 2019-07-24 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2 and integrin-binding-fc-fusion protein |
| US20170224777A1 (en) | 2014-08-12 | 2017-08-10 | Massachusetts Institute Of Technology | Synergistic tumor treatment with il-2, a therapeutic antibody, and a cancer vaccine |
| EP3313427A4 (en) * | 2015-06-26 | 2018-12-26 | Fred Hutchinson Cancer Research Center | Therapeutic peptides and methods of use thereof |
| JP6966424B2 (ja) | 2015-09-09 | 2021-11-17 | フレッド ハッチンソン キャンサー リサーチ センター | 軟骨ホーミングペプチド |
| TWI799366B (zh) | 2015-09-15 | 2023-04-21 | 美商建南德克公司 | 胱胺酸結骨架平臺 |
| EP3786292A1 (en) * | 2016-01-08 | 2021-03-03 | Maxion Therapeutics Limited | Binding members with altered diversity scaffold domains |
| US10888603B2 (en) * | 2016-02-12 | 2021-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of treating cancer cells expressing tumor-associated integrins |
| WO2017160879A1 (en) | 2016-03-15 | 2017-09-21 | The Board Of Trustees Of The Leland Stanford Junior University | Knottin-drug conjugates and methods of using the same |
| WO2018044234A1 (en) * | 2016-08-31 | 2018-03-08 | Nanyang Technological University | Cysteine-rich polypeptides and conjugates and methods of using the same |
| US10350266B2 (en) | 2017-01-10 | 2019-07-16 | Nodus Therapeutics, Inc. | Method of treating cancer with a multiple integrin binding Fc fusion protein |
| WO2018132516A1 (en) | 2017-01-10 | 2018-07-19 | Nodus Therapeutics | Combination tumor treatment with an integrin-binding-fc fusion protein and immune modulator |
| CA3049262A1 (en) | 2017-01-18 | 2018-07-26 | Fred Hutchinson Cancer Research Center | Peptide compositions and methods of use thereof for disrupting tead interactions |
| AU2018236465A1 (en) | 2017-03-16 | 2019-08-22 | Blaze Bioscience, Inc. | Cartilage-homing peptide conjugates and methods of use thereof |
| CA3064436A1 (en) | 2017-06-15 | 2018-12-20 | Blaze Bioscience, Inc. | Renal-homing peptide conjugates and methods of use thereof |
| GB201711208D0 (en) | 2017-07-12 | 2017-08-23 | Iontas Ltd | Ion channel inhibitors |
| EP3658186A4 (en) * | 2017-07-24 | 2020-08-12 | Rutgers, The State University of New Jersey | FUSION MOLECULES TARGETING PHOSPHATIDYLSERINE AND THEIR METHODS OF USE |
| JP7386161B2 (ja) | 2017-12-19 | 2023-11-24 | ブレイズ バイオサイエンス， インコーポレイテッド | 腫瘍ホーミング及び細胞透過性ペプチド免疫抗がん剤複合体、ならびにそれらの使用方法 |
| US11235032B2 (en) | 2019-01-23 | 2022-02-01 | Massachusetts Institute Of Technology | Combination immunotherapy dosing regimen for immune checkpoint blockade |
| JP2022527351A (ja) * | 2019-04-02 | 2022-06-01 | イーライ リリー アンド カンパニー | 結合ペプチドを選択し検出するための方法 |
| JP2022531191A (ja) * | 2019-04-29 | 2022-07-06 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 肝細胞増殖因子の操作された二量体断片を使用する眼の治療方法 |
| WO2020237078A1 (en) * | 2019-05-22 | 2020-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Drug conjugates and methods of using same |
| KR20220071225A (ko) * | 2019-09-30 | 2022-05-31 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 노틴-면역자극제 접합체 및 관련 조성물 및 방법 |
| US20230211001A1 (en) * | 2020-07-30 | 2023-07-06 | The Board Of Trustees Of The Leland Stanford Junior University | Lysosomal Targeting Molecules Comprising Knottin Peptides And Related Compositions And Methods |
| MX2020012914A (es) * | 2020-11-27 | 2022-05-30 | Centro De Investig Cientifica Y De Educacion Superior De Ensenada Baja California Cicese | Proteina andamio para la generacion de proteinas quimericas de union a antigeno. |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5468634A (en) | 1991-06-24 | 1995-11-21 | The University Of North Carolina At Chapel Hill | Axl oncogene |
| US6699658B1 (en) | 1996-05-31 | 2004-03-02 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6303749B1 (en) * | 1999-01-29 | 2001-10-16 | Amgen Inc. | Agouti and agouti-related peptide analogs |
| DE10053224A1 (de) * | 2000-10-26 | 2002-05-08 | Univ Goettingen Georg August | Verfahren zur Exposition von Peptiden und Polypeptiden auf der Zelloberfläche von Bakterien |
| CA2437194A1 (en) | 2001-01-31 | 2002-08-08 | Mount Sinai Hospital | Methods for regulating the kinase domain of ephb2 |
| GB0110430D0 (en) | 2001-04-27 | 2001-06-20 | Medical Res Council | Protein variants and uses thereof |
| JP5912211B2 (ja) * | 2004-01-20 | 2016-04-27 | メルス ビー．ヴィー． | 結合タンパク質の混合物 |
| EP1784424A4 (en) * | 2004-08-16 | 2009-03-18 | Medimmune Inc | EPH RECEPTOR BINDING FC VARIANTS HAVING CELLULAR CELLULAR ACTIVITY DEPENDENT ANTIBODIES |
| US7674881B2 (en) | 2005-10-07 | 2010-03-09 | The University Of Chicago | Convergent synthesis of proteins by kinetically controlled ligation |
| US7666622B2 (en) * | 2005-10-19 | 2010-02-23 | Regeneron Pharmaceuticals, Inc. | Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
| WO2008045252A2 (en) | 2006-10-04 | 2008-04-17 | The Board Of Trustees Of The Leland Stanford Junior University | Engineered integrin binding peptides |
| EP1958957A1 (en) | 2007-02-16 | 2008-08-20 | NascaCell Technologies AG | Polypeptide comprising a knottin protein moiety |
| WO2009005813A1 (en) | 2007-07-02 | 2009-01-08 | Wyeth | Modulators of axl for use in treating bone disorders |
| CN101952312A (zh) | 2007-07-31 | 2011-01-19 | 米迪缪尼有限公司 | 多特异性表位结合蛋白及其应用 |
| WO2009097017A2 (en) * | 2007-09-18 | 2009-08-06 | The Jackson Laboratory | Antibodies and fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof |
| WO2009061853A2 (en) * | 2007-11-05 | 2009-05-14 | Massachusetts Institute Of Technology | Mutant interleukin-2 (il-2) polypeptides |
| EP2349327A4 (en) | 2008-10-23 | 2012-11-28 | Massachusetts Inst Technology | COMMITMENT DIRECTED FC RECEIVERS ACTIVATORS |
| US8329826B2 (en) | 2008-11-06 | 2012-12-11 | The Board Of Trustees Of The Leland Stanford Junior University | Surface modification of interpenetrating polymer networks |
| US8778888B2 (en) * | 2009-11-06 | 2014-07-15 | The Board Of Trustees Of The Leland Stanford Junior University | Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use |
| CN103154020B (zh) | 2010-01-22 | 2017-03-15 | 小利兰·斯坦福大学托管委员会 | 抗转移疗法中axl信号传导的抑制 |
| AU2011326164B2 (en) | 2010-11-08 | 2016-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| US10350266B2 (en) * | 2017-01-10 | 2019-07-16 | Nodus Therapeutics, Inc. | Method of treating cancer with a multiple integrin binding Fc fusion protein |
-
2011
- 2011-11-07 AU AU2011326164A patent/AU2011326164B2/en not_active Ceased
- 2011-11-07 DK DK11839687.8T patent/DK2638173T3/da active
- 2011-11-07 EP EP11839687.8A patent/EP2638173B1/en active Active
- 2011-11-07 EP EP19180924.3A patent/EP3604549A1/en not_active Withdrawn
- 2011-11-07 US US13/883,216 patent/US10844106B2/en active Active
- 2011-11-07 WO PCT/US2011/059599 patent/WO2012064658A1/en not_active Ceased
- 2011-11-07 CA CA2817197A patent/CA2817197C/en active Active
- 2011-11-07 JP JP2013537908A patent/JP6170435B2/ja active Active
-
2016
- 2016-08-04 AU AU2016210712A patent/AU2016210712B2/en not_active Ceased
-
2017
- 2017-04-13 JP JP2017079525A patent/JP6535361B2/ja active Active
-
2018
- 2018-01-24 AU AU2018200587A patent/AU2018200587B2/en not_active Ceased
-
2020
- 2020-10-08 US US17/066,167 patent/US11498952B2/en active Active
-
2022
- 2022-11-14 US US18/055,297 patent/US12240882B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017160222A5 (OSRAM) | ||
| CN111148756B (zh) | T细胞受体 | |
| ES2991142T3 (es) | Receptores de linfocitos T | |
| US11254729B2 (en) | IL-7R-α binding compounds | |
| JP2016053091A5 (OSRAM) | ||
| JP2018198596A5 (OSRAM) | ||
| CN102307896A (zh) | 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途 | |
| JP2017529067A5 (OSRAM) | ||
| JP2014519830A5 (OSRAM) | ||
| JP2019506841A5 (OSRAM) | ||
| JP2023081303A5 (OSRAM) | ||
| JP2013505734A5 (OSRAM) | ||
| RU2015100656A (ru) | Способ получения конъюгатов fc-фрагмента антитела, включающих по меньшей мере одну связывающую группировку, которая специфически связывается с мишенью, и их применения | |
| JP2018511327A5 (OSRAM) | ||
| JP2018535196A5 (OSRAM) | ||
| JP2017537622A5 (OSRAM) | ||
| JP2012501959A5 (OSRAM) | ||
| JP2015505299A5 (OSRAM) | ||
| JP2017113019A5 (OSRAM) | ||
| JP2014523238A5 (OSRAM) | ||
| JP2011502479A5 (OSRAM) | ||
| JP2019536426A5 (OSRAM) | ||
| JP2018528237A5 (OSRAM) | ||
| JP2013529178A5 (OSRAM) | ||
| JP2018512124A5 (OSRAM) |